These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26517158)

  • 1. Understanding and Controlling Cost in Total Joint Arthroplasty.
    Alvarado CM; Bosco J
    Bull Hosp Jt Dis (2013); 2015 Jun; 73(2):70-7. PubMed ID: 26517158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value-based Healthcare: Preoperative Assessment and Global Optimization (PASS-GO): Improving Value in Total Joint Replacement Care.
    Vetter TR; Uhler LM; Bozic KJ
    Clin Orthop Relat Res; 2017 Aug; 475(8):1958-1962. PubMed ID: 28600689
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct hospital cost determinants following hip and knee arthroplasty.
    Peel TN; Cheng AC; Liew D; Buising KL; Lisik J; Carroll KA; Choong PF; Dowsey MM
    Arthritis Care Res (Hoboken); 2015 May; 67(6):782-90. PubMed ID: 25470687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA.
    Bozic KJ; Kamath AF; Ong K; Lau E; Kurtz S; Chan V; Vail TP; Rubash H; Berry DJ
    Clin Orthop Relat Res; 2015 Jun; 473(6):2131-8. PubMed ID: 25467789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value-based Healthcare: Increasing Value by Reducing Implant-related Health Care Costs.
    Waldrop VH; Laverty DC; Bozic KJ
    Clin Orthop Relat Res; 2019 Feb; 477(2):281-283. PubMed ID: 29762154
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreasing total joint implant costs and physician specific cost variation through negotiation.
    Bosco JA; Alvarado CM; Slover JD; Iorio R; Hutzler LH
    J Arthroplasty; 2014 Apr; 29(4):678-80. PubMed ID: 24134928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making progress on ortho implant costs.
    OR Manager; 2005 Jun; 21(6):21-2. PubMed ID: 16022240
    [No Abstract]   [Full Text] [Related]  

  • 8. The economics of new age arthroplasty: can we afford it?
    Sculco TP
    Orthopedics; 2010 Sep; 33(9):628. PubMed ID: 20839675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of surgical case order on peri-operative outcomes for total joint arthroplasty.
    Li X; Zhang Q; Dong J; Zhang G; Chai W; Chen J
    Int Orthop; 2018 Oct; 42(10):2289-2294. PubMed ID: 29445962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision making and the cost effectiveness of our interventions.
    Haddad FS
    Bone Joint J; 2015 Apr; 97-B(4):433. PubMed ID: 25820878
    [No Abstract]   [Full Text] [Related]  

  • 11. What Are the Uses and Limitations of Time-driven Activity-based Costing in Total Joint Replacement?
    Pathak S; Snyder D; Kroshus T; Keswani A; Jayakumar P; Esposito K; Koenig K; Jevsevar D; Bozic K; Moucha C
    Clin Orthop Relat Res; 2019 Sep; 477(9):2071-2081. PubMed ID: 31107316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgeons' Perspectives on Premium Implants in Total Joint Arthroplasty.
    Wasterlain AS; Bello RJ; Vigdorchik J; Schwarzkopf R; Long WJ
    Orthopedics; 2017 Sep; 40(5):e825-e830. PubMed ID: 28662250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbar spinal fusion versus anterior lumbar disc replacement: the financial implications.
    Patel VV; Estes S; Lindley EM; Burger E
    J Spinal Disord Tech; 2008 Oct; 21(7):473-6. PubMed ID: 18836357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying opportunities for hospital cost control: medical device purchasing and patient discharge planning.
    Robinson JC; Brown TT
    Am J Manag Care; 2014 Sep; 20(9):e418-24. PubMed ID: 25364878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health and economic burden of diabetes in Bangladesh: Priorities for attention and control.
    Sarker AR; Sultana M
    J Diabetes; 2017 Dec; 9(12):1118-1119. PubMed ID: 28749030
    [No Abstract]   [Full Text] [Related]  

  • 16. Infinite needs--finite resources: the future of healthcare.
    Lamm RD
    Camb Q Healthc Ethics; 1994; 3(1):83-98. PubMed ID: 8032523
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of severity of disease on cost burden of 30-day readmissions following total joint arthroplasty (TJA).
    Kiridly DN; Karkenny AJ; Hutzler LH; Slover JD; Iorio R; Bosco JA
    J Arthroplasty; 2014 Aug; 29(8):1545-7. PubMed ID: 24793571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Friendly competition' lowers costs.
    OR Manager; 2000 Sep; 16(9):24-5. PubMed ID: 11187287
    [No Abstract]   [Full Text] [Related]  

  • 19. Total joint replacement program prevents costly complications.
    Healthc Demand Dis Manag; 1999 Jan; 5(1):9-12. PubMed ID: 10345828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing Hospital Readmissions and Limiting the Complications Associated With Total Joint Arthroplasty.
    Yu S; Garvin KL; Healy WL; Pellegrini VD; Iorio R
    J Am Acad Orthop Surg; 2015 Nov; 23(11):e60-71. PubMed ID: 26498587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.